1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow MYL-1701P: new trials by email Literature Review of MYL-1701P trials Research Report on MYL-1701P
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) MYL-1701P, Eylea - Diabetic Macular Edema | Phase 3 | Completed | Mylan Pharmaceuticals Inc | 355 | 2018-08-23 | 2023-03-07 |
Czechia (1) · Germany (1) · Hungary (1) · India (1) · Japan (1) · Latvia (1) · Poland (1) · Russia (1) · United States (1)